| Name | Title | Contact Details |
|---|
Fallon Medicca is a Tinton Falls, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We are one of the nation`s first health departments and trace our roots back to 1799, when Paul Revere was named Boston`s first health officer. Back then, the board of health was formed to fight a potential outbreak of cholera. Taking innovative strides to save lives, health officials posted signs on lampposts, held meetings and led an early-day public information campaign to reduce deaths due to cholera, a highly preventable disease. Two hundred years later, that tradition of prevention continues through the Boston Public Health Commission. While we are the country`s oldest health department, we pride ourselves on having some of the most innovative services for our residents. Described as "the most activist arm of city government," by the Boston Globe, the Commission has a vigorous commitment to the health of Boston.
McBride Orthopedic Hospital opened in 2005 as a full-service orthopedic hospital. McBride has grown to include a board-certified physician staff of 28, practicing at five metro locations and several outreach clinics in rural communities. The physicians continue their close involvement with athletes of all ages, serving as team physicians for many of the local professional, collegiate, and high school athletes.
Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.
We are one of the oldest and largest non-profit human service agencies in Rhode Island. Our offices are located in Providence and North Kingstown, with children's residential treatment facilities in Smithfield, North Smithfield, Bristol, and East